Clinical Trial Update: The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients [NA]

View source ↗

Summary

A clinical trial in diabetic patients investigates whether adding copper can prevent cytokine-induced reductions in glucose-stimulated insulin secretion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperglycemia

Drugs mentioned

• Copper (copper)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Hyperglycemia, Diabetes | NA | Status: UNKNOWN